Key result
Rosiglitazone treatment of primary human adipocytes induced brite phenotypes, with lipid droplets acquiring paucilocular morphology (clusters of 1-2 micron droplets) after 60+ days in culture.
Why the study?
To investigate remodeling of cellular metabolism and structures during browning of primary human adipocytes from visceral and subcutaneous tissues, including glucocorticoid effects.
Does rosiglitazone with or without dexamethasone induce browning and structural remodeling in primary human adipocytes?
Does rosiglitazone with or without dexamethasone induce browning and structural remodeling in primary human adipocytes?
Rosiglitazone induces metabolic and structural remodeling in primary human adipocytes, producing brite phenotypes similar to in vivo findings.
Glucocorticoid effects on human adipocyte browning require in vivo confirmation; leaves open any clinical relevance for obesity.
OBJECTIVE: This study investigated remodeling of cellular metabolism and structures during browning of primary human adipocytes derived from both visceral and subcutaneous adipose tissues. Effects of glucocorticoids on the browning were also assessed. METHODS: Differentiated omental and subcutaneous human adipocytes were treated with rosiglitazone, with or without dexamethasone, and expression levels of brite adipocyte markers, lipolysis, and lipid droplet and mitochondrial structures were examined. RESULTS: Both omental and subcutaneous adipocytes acquired brite phenotypes upon peroxisome proliferator-activated receptor-γ agonist treatment, and dexamethasone tended to enhance the remodeling. Although rosiglitazone increased lipolysis during treatment, brite adipocytes exhibited lower basal lipolytic rates and enhanced responses to β-adrenergic agonists or atrial natriuretic peptide. Transcriptome analysis identified induction of both breakdown and biosynthesis of lipids in brite adipocytes. After 60+ days in culture, lipid droplet size increased to ~50 microns, becoming almost unilocular in control adipocytes, and after browning, they acquired paucilocular morphology, clusters of small lipid droplets (1-2 micron) surrounded by mitochondria appearing on the periphery of the central large one. CONCLUSIONS: Metabolic and structural remodeling during browning of primary human adipocytes is similar to previous findings in human adipocytes in vivo, supporting their uses for mechanical studies investigating browning with translational relevance.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2023) studied this question. Rosiglitazone with or without dexamethasone vs. Control adipocytes was evaluated on Expression levels of brite adipocyte markers, lipolysis, and lipid droplet and mitochondrial structures. Rosiglitazone treatment of primary human adipocytes induced brite phenotypes, with lipid droplets acquiring paucilocular morphology (clusters of 1-2 micron droplets) after 60+ days in culture.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: